What happened to the takeover bid for Monash IVF?

The A$311.7 million takeover proposal for Monash IVF has been withdrawn by the consortium that made the offer.

Why did Monash IVF shares fall after the bid withdrawal?

Monash IVF shares dropped significantly because the potential acquisition, which offered a premium, was no longer proceeding.

Did Monash IVF's board want the takeover offer?

No, the Monash IVF board considered the offer opportunistic and materially undervalued the company.

Home / Business and Economy / Monash IVF Takeover Bid Collapses

Monash IVF Takeover Bid Collapses

24 Dec, 2025

•

Summary

A takeover proposal valued at A$311.7 million has been withdrawn.
Monash IVF shares dropped over 15% following the withdrawal.
The board previously deemed the offer opportunistic and undervalue.

The A$311.7 million takeover proposal for Monash IVF Group has been formally withdrawn, significantly impacting the company's stock. Shares of the Australian fertility provider fell sharply by more than 15% to A$0.69, marking a one-month low following the announcement.

The non-binding offer, made in November by Genesis Capital Investment Management and WHSP Holdings, was for A$0.80 per share. Monash IVF's board had previously stated their view that the proposal was opportunistic and materially undervalued the company, a sentiment echoed by market analysts who attributed Wednesday's stock drop to thin holiday markets.

This development follows earlier challenges for Monash IVF, including two embryo mix-up incidents earlier in the year which led to the departure of its former CEO. Market observers anticipate a potential recovery in confidence for the company in the coming year.